Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers - Related Studies

Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers

This study is currently recruiting participants.

Study NCT00636558. Last updated on April 11, 2008. Information provided by Viralytics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma
		Breast Cancer
		Prostate Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Coxsackievirus Infections
		Prostatic Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Enterovirus Infections
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Picornaviridae Infections
		Prostatic Diseases
		RNA Virus Infections
		Skin Diseases
		Urogenital Neoplasms
		Virus Diseases

4	Interventions listed in this trial
		CVA21

5	Sponsors listed in this trial
		Viralytics